CASI Pharmaceuticals, Inc. (CASI) Financials
CASI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 75.3 million | 51.1 million |
2023-09-30 | 74.2 million | 23.8 million |
2023-06-30 | 77.9 million | 24.0 million |
2023-03-31 | 88.4 million | 26.2 million |
CASI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | 7.2 million |
2023-09-30 | ? | ? |
2023-06-30 | ? | ? |
2023-03-31 | -4.3 million | 1.4 million |
CASI Net Income
No data available :(
CASI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 30.8 million | - | 2.3 million |
2023-09-30 | 35.6 million | - | - |
2023-06-30 | 38.8 million | - | - |
2023-03-31 | 44.3 million | - | - |
CASI Shares Outstanding
CASI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | -1.9 million | 6.4 million | 5.2 million |
2023-09-30 | - | 2.4 million | 5.5 million | 2.5 million |
2023-06-30 | - | 2.6 million | 7.7 million | 4.8 million |
2023-03-31 | 3.4 million | 2.5 million | 5.7 million | 4.0 million |
CASI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 6.1 million | 2.3 million |
2023-09-30 | 8.8 million | 3.6 million |
2023-06-30 | 9.8 million | 4.0 million |
2023-03-31 | 8.3 million | 3.4 million |
CASI
Price: $2.42
52 week price:
Earnings Per Share: -2.02 USD
P/E Ratio: -2.08
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 21900
Ebitda: -1.6 millionMarket Capitalization: 32.7 million